Literature DB >> 19242647

Population-specific spectrum of NOTCH3 mutations, MRI features and founder effect of CADASIL in Chinese.

Yi-Chung Lee1, Chin-San Liu, Ming-Hong Chang, Kon-Ping Lin, Jong-Ling Fuh, Yi-Chu Lu, Ya-Fen Liu, Bing-Wen Soong.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a hereditary disorder caused by NOTCH3 mutations and characterized by recurrent subcortical infarctions, dementia and leukoencephalopathy. So far, most clinical, molecular and neuroimaging information has come from Caucasians. Therefore, we investigated the spectrum of NOTCH3 mutations and MRI features in CADASIL patients of Chinese origin on Taiwan.
METHODS: Mutational analysis of NOTCH3 exons 2 to 23 by direct nucleotide sequencing was performed in patients with clinically suspected CADASIL. MRI findings were retrospectively evaluated and scored using a modified Schelten's scale.
RESULTS: Nine different point mutations of NOTCH3 were identified in 21 unrelated patients. Intriguingly, 47.6 % were in exon 11, and 19 % in each of exon 4 and 18. R544C was very common and present in all patients with a mutation in exon 11. Many patients with NOTCH3 R544C share the same haplotype linked to the mutation using markers D19S929 and D19S411, which flank the NOTCH3. The sensitivity of T2-weighted MRI detecting anterior temporal abnormality was only 42.9 %. Furthermore, the neuroimaging evidence of intracerebral hemorrhage (ICH) was present in 23.8 % of the 21 patients.
CONCLUSIONS: A population-specific mutational spectrum of CADASIL was found in the Chinese patients on Taiwan. The Chinese patients carrying NOTCH3 R544C may descend from a common ancestor. Anterior temporal hyperintensity on T2-weighted MRI may not be a sensitive marker for CADASIL. ICH is a relatively common manifestation of CADASIL in East Asians, especially in the presence of hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19242647     DOI: 10.1007/s00415-009-0091-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  23 in total

1.  The spectrum of Notch3 mutations in 28 Italian CADASIL families.

Authors:  M T Dotti; A Federico; R Mazzei; S Bianchi; O Scali; F L Conforti; T Sprovieri; D Guidetti; U Aguglia; D Consoli; L Pantoni; C Sarti; D Inzitari; A Quattrone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

2.  Cerebellar arteriovenous malformation and vertebral artery aneurysm in a CADASIL patient.

Authors:  F Pescini; C Sarti; L Pantoni; S Mangiafico; S Bianchi; M T Dotti; A Federico; D Inzitari
Journal:  Acta Neurol Scand       Date:  2006-01       Impact factor: 3.209

3.  MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL.

Authors:  M O'Sullivan; J M Jarosz; R J Martin; N Deasy; J F Powell; H S Markus
Journal:  Neurology       Date:  2001-03-13       Impact factor: 9.910

4.  Spectrum of mutations in biopsy-proven CADASIL: implications for diagnostic strategies.

Authors:  Nils Peters; Christian Opherk; Tanja Bergmann; Mirna Castro; Jürgen Herzog; Martin Dichgans
Journal:  Arch Neurol       Date:  2005-07

5.  Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia.

Authors:  A Joutel; C Corpechot; A Ducros; K Vahedi; H Chabriat; P Mouton; S Alamowitch; V Domenga; M Cécillion; E Marechal; J Maciazek; C Vayssiere; C Cruaud; E A Cabanis; M M Ruchoux; J Weissenbach; J F Bach; M G Bousser; E Tournier-Lasserve
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

Review 6.  Notch signaling.

Authors:  S Artavanis-Tsakonas; K Matsuno; M E Fortini
Journal:  Science       Date:  1995-04-14       Impact factor: 47.728

7.  Intracerebral hemorrhages in CADASIL.

Authors:  Jay Chol Choi; Sa-Yoon Kang; Ji-Hoon Kang; Ji-Kang Park
Journal:  Neurology       Date:  2006-11-29       Impact factor: 9.910

8.  [NOTCH3 gene mutations in four Chinese families with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy].

Authors:  Zhao-xia Wang; He Lu; Ying Zhang; Ding-fang Bu; Xiao-yuan Niu; Zhuo Zhang; Yi-ning Huang; Yun Yuan
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2004-07-17

9.  Pathogenic mutations associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy differently affect Jagged1 binding and Notch3 activity via the RBP/JK signaling Pathway.

Authors:  Anne Joutel; Marie Monet; Valérie Domenga; Florence Riant; Elisabeth Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2004-01-08       Impact factor: 11.025

10.  Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  H Chabriat; K Vahedi; M T Iba-Zizen; A Joutel; A Nibbio; T G Nagy; M O Krebs; J Julien; B Dubois; X Ducrocq
Journal:  Lancet       Date:  1995-10-07       Impact factor: 79.321

View more
  26 in total

Review 1.  Imaging characteristics of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL).

Authors:  Dragan Stojanov; Slobodan Vojinovic; Aleksandra Aracki-Trenkic; Aleksandar Tasic; Daniela Benedeto-Stojanov; Srdjan Ljubisavljevic; Sasa Vujnovic
Journal:  Bosn J Basic Med Sci       Date:  2015-02-09       Impact factor: 3.363

2.  Clinical features and mutation spectrum in Chinese patients with CADASIL: A multicenter retrospective study.

Authors:  Sheng Chen; Wang Ni; Xin-Zhen Yin; Han-Qiu Liu; Cong Lu; Qiao-Juan Zheng; Gui-Xian Zhao; Yong-Feng Xu; Lei Wu; Liang Zhang; Ning Wang; Hong-Fu Li; Zhi-Ying Wu
Journal:  CNS Neurosci Ther       Date:  2017-07-14       Impact factor: 5.243

3.  Two novel mutations in NOTCH3 gene causes cerebral autosomal dominant arteriopathy with subcritical infarct and leucoencephalopathy in two Chinese families.

Authors:  Yuyou Zhu; Juan Wang; Yuanbo Wu; Guoping Wang; Bai Hu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  Genotypic and phenotypic spectrum of CADASIL in Japan: the experience at a referral center in Kumamoto University from 1997 to 2014.

Authors:  Akihiko Ueda; Mitsuharu Ueda; Akihito Nagatoshi; Teruyuki Hirano; Takaaki Ito; Nobutaka Arai; Eiichiro Uyama; Kota Mori; Masaaki Nakamura; Satoru Shinriki; Katsuyoshi Ikeda; Yukio Ando
Journal:  J Neurol       Date:  2015-05-16       Impact factor: 4.849

5.  Mutation spectrum and genotype-phenotype correlations in 157 Korean CADASIL patients: a multicenter study.

Authors:  Ji-You Min; Seo-Jin Park; Eun-Joo Kang; Seung-Yong Hwang; Sung-Hee Han
Journal:  Neurogenetics       Date:  2021-11-06       Impact factor: 2.660

6.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a genetic cause of cerebral small vessel disease.

Authors:  Jay Chol Choi
Journal:  J Clin Neurol       Date:  2010-03-26       Impact factor: 3.077

7.  De novo mutation in the NOTCH3 gene causing CADASIL.

Authors:  Dragan Stojanov; Danijela Grozdanović; Sladjana Petrović; Daniela Benedeto-Stojanov; Ivan Stefanović; Nebojša Stojanović; Dušica N Ilić
Journal:  Bosn J Basic Med Sci       Date:  2014-02       Impact factor: 3.363

8.  Phenotypic characterization of CADASIL patients with the Arg332Cys mutation in the NOTCH3.

Authors:  Chen-Si Li; Tian-Wei Wang; Jie Wang; Shuai-Hong Li; Na Li; Xiao-Shuang Wang; Le Fang
Journal:  Ann Transl Med       Date:  2020-01

9.  Characterization of CADASIL among the Han Chinese in Taiwan: Distinct Genotypic and Phenotypic Profiles.

Authors:  Yi-Chu Liao; Cheng-Tsung Hsiao; Jong-Ling Fuh; Chang-Ming Chern; Wei-Ju Lee; Yuh-Cherng Guo; Shuu-Jiun Wang; I-Hui Lee; Yo-Tsen Liu; Yen-Feng Wang; Feng-Chi Chang; Ming-Hung Chang; Bing-Wen Soong; Yi-Chung Lee
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

10.  Spontaneous intracerebral hemorrhage in CADASIL.

Authors:  Lifei Lian; Dujuan Li; Zheng Xue; Qiming Liang; Feng Xu; Huicong Kang; Xiaoyan Liu; Suiqiang Zhu
Journal:  J Headache Pain       Date:  2013-12-17       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.